Xinrong Zhai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xinrong Zhai has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Kailei Shi
Huadong Hospital Affiliated to Fudan University
1 shared publicationMaoqing Ye
Huadong Hospital Affiliated to Fudan University
1 shared publicationShaofeng Guan
Huadong Hospital Affiliated to Fudan University
1 shared publicationShuyi Zhang
Huadong Hospital Affiliated to Fudan University
1 shared publication- Wenzheng Han
Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publication Xinkai Qu
Huadong Hospital Affiliated to Fudan University
1 shared publication
Latest Publications
- Open Access
- 19 April 2023
- Published by Springer Nature in Research Square
Invasive versus noninvasive management of older patients with non-ST elevation ACS: A retrospective analysis
Purpose: The aim of this study was to evaluate the efficacy of invasive versus noninvasive management in patients aged 80 years or older with non-ST-elevation acute coronary syndrome (NSTEACS). Methods: All 220 included patients were at least 80 years old at the time of diagnosis. We compared the prognoses of patients in the invasive group and the noninvasive group. The primary endpoint was all-causemortality, and the secondary endpoint was the occurrence of events, including readmission or visit to a chest pain center due to a myocardial ischemic event, heart failure or major bleeding. Results: The median age was 84 years (IQR 83-87), and older patients were more likely to receive noninvasiveinterventions (OR 0.82, 95% CI 0.74-0.92). The mortality HR when comparing noninvasive management with invasive management was 5.52 (95% CI1.80-16.92). When adjusted for diagnosis (UA or NSTEMI), the mortality HR increased to 6.17 (95% CI 2.04-18.64). Noninvasive management was associated with a higher incidence of events (HR 2.96, 95% CI1.51-5.82). However, no significant differences were observed in mortality or event HR when comparing complete revascularization with culprit-only percutaneous coronary intervention (PCI). Conclusions: For patients aged 80 years or older with NSTEACS, invasive management might be a better choice than noninvasive management. In terms of PCI strategy, culprit-only PCI could be considered.
- 19 April 2023
- Published by Springer Nature in Research Square
Open AccessInvasive versus noninvasive management of older patients with non-ST elevation ACS: A retrospective analysis
Purpose: The aim of this study was to evaluate the efficacy of invasive versus noninvasive management in patients aged 80 years or older with non-ST-elevation acute coronary syndrome (NSTEACS). Methods: All 220 included patients were at least 80 years old at the time of diagnosis. We compared the prognoses of patients in the invasive group and the noninvasive group. The primary endpoint was all-causemortality, and the secondary endpoint was the occurrence of events, including readmission or visit to a chest pain center due to a myocardial ischemic event, heart failure or major bleeding. Results: The median age was 84 years (IQR 83-87), and older patients were more likely to receive noninvasiveinterventions (OR 0.82, 95% CI 0.74-0.92). The mortality HR when comparing noninvasive management with invasive management was 5.52 (95% CI1.80-16.92). When adjusted for diagnosis (UA or NSTEMI), the mortality HR increased to 6.17 (95% CI 2.04-18.64). Noninvasive management was associated with a higher incidence of events (HR 2.96, 95% CI1.51-5.82). However, no significant differences were observed in mortality or event HR when comparing complete revascularization with culprit-only percutaneous coronary intervention (PCI). Conclusions: For patients aged 80 years or older with NSTEACS, invasive management might be a better choice than noninvasive management. In terms of PCI strategy, culprit-only PCI could be considered.